🔥 Wednesday 29 April 2026 Wed, 29 Apr 2026

Mont Royal Resources is on track to release an updated Preliminary Economic Assessment for its Ashram Rare Earths project in May, with a promising geological review highlighting the BD-Zone as a key area for resource expansion. The company also secured a strategic non-binding MOU with Saguenay Port Authority and extended funding for critical infrastructure.

Ordell Minerals has reported multiple high-grade gold intersections at its Barimaia project’s McNabs East Prospect, underpinning a 15,000m drilling program planned for May to July 2026 targeting resource growth and new discoveries.

Syrah Resources delivered a record 24kt graphite production at Balama and secured US$72 million in equity to support medium-term ramp-up and Vidalia commercialisation, navigating a complex US trade environment.

Avecho Biotechnology has exceeded its Phase III CBD insomnia trial recruitment target by 16%, setting the stage for a more robust interim analysis scheduled for June 2026. The company’s commercial partnership with Sandoz AG and strengthened patent portfolio underpin its Australian market strategy.

Prospect Resources has delivered further gold assay results from its Nyungu Central deposit, reinforcing the potential for valuable by-product credits at the Mumbezhi Copper Project and setting the stage for an aggressive Phase 3 drilling campaign.

TrivarX appoints Dr Danielle Meyrick as CEO to spearhead clinical trials and commercialisation of its novel stable isotope MRI brain cancer imaging platform, with Phase 1 studies on track for completion this year.

Mamba Exploration has secured a controlling stake in the Meeka East Gold Project, bolstered by a $2 million capital raise and promising early exploration work including extensive soil sampling and historic data validation.

Metal Powder Works has scaled its NextGen powder production to 100 metric tonnes per annum with an industry-leading saleable yield above 95%, setting the stage for an 800MT capacity by 2028 at a fraction of conventional costs.

Nova Eye Medical reported a 23% rise in quarterly sales to US$5.8 million, driven by strong US growth and initial Chinese sales. EBITDA loss narrowed significantly, with positive operational EBITDA recorded.

Sea Forest Limited’s 3Q26 revenue surged 92% to $1.1 million, boosted by expanding SeaFeed™ sales and a pioneering low-carbon wool launch with Theory. New cattle supply deals raise herd commitments to 131,000, underpinning growth amid supportive government policies.

Lotus Resources has completed the first phase of a 10,000m infill drill program at its Letlhakane Uranium Project, revealing significant higher-grade uranium intercepts that underpin a resource upgrade planned for H2 2026.

RocketDNA Ltd delivered a break-even operating cash flow quarter with $2.47 million revenue, driven by soaring autonomous drone usage and the debut of its Skylink® operating system.

Enlitic delivered its strongest quarter yet with A$5.1 million in contracts, including significant agreements with Penn Medicine, St. Jude Children’s Research Hospital, and Parkland Health, while improving cash flow and advancing its AI-powered Ensight platform.

Toubani Resources has kicked off construction at its Kobada Gold Project in Mali following a positive Final Investment Decision, while securing a US$83.5 million financing package to support development.

Invictus Energy is gearing up for a pivotal drilling campaign in Zimbabwe's Cabora Bassa Basin, targeting a multi-Tcf gas and condensate resource that could reshape Southern Africa's energy landscape.

AdAlta has secured Australian manufacturing for its lead CAR-T therapy BZDS1901, which has shown rare complete tumour clearance in advanced mesothelioma patients. This move is a key step toward local clinical trials and boosts the therapy’s global commercial appeal.

Octava Minerals has delivered its first drilling results in nearly 50 years at the Federation Project in Tasmania, revealing significant copper, indium, tin, antimony, lead, and zinc mineralisation across multiple styles.

Alcidion Group delivered positive cashflow and strong new sales in Q3 FY26, with contract expansions in the UK and Australia. The company remains on track for a significant Electronic Patient Record contract signing in May.

Alicanto Minerals has kicked off a 50,000-metre drilling campaign to expand the 915,000oz Mt Henry gold resource, backed by a fresh $18.1 million non-dilutive funding package and key leadership changes.

FMR Resources wraps up Phase I drilling at its Chilean Llahuin Project, revealing extensive mineralised porphyry zones, while initial assays from Canada’s Goshen Prospect affirm a copper system. The company holds $3.1 million in cash and plans Phase II drilling.

Brightstar Resources (ASX:BTR) has fully funded its Goldfields Project development with a $193 million equity raise and a US$120 million senior secured bond, targeting 75,000oz gold production from mid-2027 while progressing Sandstone towards a Final Investment Decision.

Middle Island Resources has completed its Phase 2 drilling at the Bobija polymetallic project in Serbia, reinforcing continuity of gold-silver-base metal mineralisation. Extensive soil sampling across Tisovik, Priboj, and Ober projects has identified multiple promising targets, with RC drilling planned pending land access approvals.

Ardea Resources is progressing its Kalgoorlie Nickel Project’s Definitive Feasibility Study with strong financial and strategic support from a Japanese Consortium and government export banks, aiming to secure a major nickel-cobalt supply chain.

Catalyst Metals reported stable gold production at Plutonic despite rising costs, unveiled a promising new ore source at Cinnamon, and expanded its landholdings significantly in the Bryah Basin.